Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Releases

22398 Press Releases
DateTitleCompany
20 Nov 17 ZIOPHARM Presents Positive Updated Results of Ad-RTS-hIL-12 Study in Brain Cancer at Society for Neuro-Oncology Annual Meeting Published by
GlobeNewswire
20 Nov 17 Protalix BioTherapeutics Announces Presentation to be made at the New Horizons in Fabry Disease Conference Published by
GlobeNewswire
20 Nov 17 Recro Pharma Secures $100 Million Credit Facility Published by
GlobeNewswire
20 Nov 17 Kamada and Chiesi Farmaceutici S.p.A. Mutually Agree to Terminate European Distribution Agreement for Inhaled Alpha-1 Antitrypsin Therapy for Treatment of Alpha-1 Antitrypsin Deficiency Published by
GlobeNewswire
20 Nov 17 Intra-Cellular Therapies Receives FDA Fast Track Designation for Lumateperone for the Treatment of Schizophrenia Published by
GlobeNewswire
20 Nov 17 Emergent BioSolutions Receives FDA Approval to Manufacture ACAM2000 at Canton, Massachusetts Facility Published by
GlobeNewswire
20 Nov 17 Deciphera Pharmaceuticals Reports Data from Ongoing Phase 1 Clinical Study of DCC-2618 at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology Published by
GlobeNewswire
20 Nov 17 Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference Published by
GlobeNewswire
20 Nov 17 Orphazyme A/S: Completion of the Offering and registration of share capital increase Published by
GlobeNewswire
20 Nov 17 Summit Completes Initial 24 Weeks of Dosing of Ezutromid in Patients With DMD in PhaseOut DMD Clinical Trial Published by
GlobeNewswire
20 Nov 17 Summit Completes Initial 24 Weeks of Dosing of Ezutromid in Patients with DMD in PhaseOut DMD Clinical Trial Summit Therapeutics plc,
Published by
GlobeNewswire
20 Nov 17 Orphazyme A/S: Completion of the Offering and registration of share capital increase Orphazyme A/S,
Published by
GlobeNewswire
20 Nov 17 Canopy Growth Welcomes Sweetgrass Inc. as Newest Craftgrow Partner Canopy Growth Corporation,
Published by
PR Newswire
20 Nov 17 Benchmark Senior Living Named Top Place to Work by The Boston Globe for 10th Consecutive Year Benchmark Senior Living,
Published by
PR Newswire
20 Nov 17 ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center ITUS Corporation,
Published by
PR Newswire
20 Nov 17 NanoViricides Files Quarterly Report for Period Ending September 30, 2017 NanoViricides, Inc.,
Published by
PR Newswire
20 Nov 17 BioLineRx Announces Partial Results of BL-8040 COMBAT Study Accepted for Presentation at ASCO 2018 Gastrointestinal Cancers Symposium BioLineRx Ltd.,
Published by
PR Newswire
20 Nov 17 CanniMed Therapeutics Inc. Announces Director Resignation CanniMed Therapeutics Inc.,
Published by
Business Wire
20 Nov 17 Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Officer Gamida Cell,
Published by
Business Wire
20 Nov 17 TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting TiGenix,
Published by
GlobeNewswire
20 Nov 17 Orphazyme A/S: No termination or withdrawal of Orphazyme's IPO Orphazyme A/S,
Published by
GlobeNewswire
20 Nov 17 Navamedic ASA: Enters into long-term agreement for distribution of GoNitro®* in the Nordics Navamedic ASA,
Published by
GlobeNewswire
20 Nov 17 DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients DBV Technologies,
Published by
GlobeNewswire
20 Nov 17 Novartis drug Tasigna® (nilotinib) secures EU approval for first and second-line treatment of Ph+ CML-CP in children Novartis International AG,
Published by
GlobeNewswire
20 Nov 17 MDxhealth teams up with Pharmaceutical Company Ferrer for distribution of its Prostate Cancer test SelectMDx in Spain MDxHealth (R),
Published by
GlobeNewswire
20 Nov 17 TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting Published by
GlobeNewswire
20 Nov 17 MRI Uncovers Brain Abnormalities in People with Depression and Anxiety Radiological Society of North America (RSNA),
Published by
PR Newswire
20 Nov 17 HSA Administrators, Clarity Benefit Solutions, Shares Ways to Help Employees Prepare for the Unexpected Clarity Benefit Solutions,
Published by
PR Newswire
20 Nov 17 Deep dive into lung cancer genomics offers new lens and lease on life Genome British Columbia,
Published by
PR Newswire
20 Nov 17 Hearing Aids Market - Forecast to 2022 - Market Breakdown by Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant - Research and Markets Research and Markets,
Published by
Business Wire
Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.